October 17th, 2005 • The Conference Center • Harvard Medical School • 77 Avenue Louis Pasteur • Boston, MA 02115

The speakers' presentations


Dr. Paul BENKIMOUN

Dr. Peter ALDHOUS (376 ko)
San Francisco Bureau Chief of New Scientist
Gene therapy's rocky media ride, and its lessons for stem-cell therapy.

Dr. Arhel

Dr. Nathalie ARHEL (1,1 Mo)
Post-doc, Pasteur Institute, Paris (replace Dr. Charneau)
HIV-1 Genome Nuclear Import and Gene Transfer Vectors: myths and reality.

Dr. Paul BENKIMOUN

Dr. Paul BENKIMOUN (52 ko)
Journalist, Le Monde, Paris-France
Writing on Gene Therapy for the lay reader.

Dr. André CHOULIKA

Dr. André CHOULIKA (1,8 Mo)
CEO, Cellectics, Romainville-France
Meganuclease based Genome Surgery.

Dr. Olivier DANOS

 

Dr. Olivier DANOS (1,1 Mo)
Scientific director of Genethon, Evry-France (replace Dr. Garcia)
Gene Therapy of Duchenne Muscular Dystrophy through Exon Skipping.

Mr. Philip D. Grégory

Dr. Philip D. GREGORY (2,3 Mo)
Senior Director, Research for Sangamo BioSciences
The Development of Novel Human Therapeutics Based Upon Engineered Zinc Finger DNA Binding Proteins.

Dr. Katherine HIGH

Dr. Katherine HIGH (2,4 Mo)
President of the American Society of Gene Therapy, Hematology Researcher at the Children’s Hospital of Philadelphia-PA
AAV, Mediated Gene Transfer for hemophilia.

Dr. Rudolf JAENISCH

Dr. Rudolf JAENISCH (1,9 Mo)
Professor of Biology, Massachusetts Institute of Technology, Boston-MA
Stem Cells, Nuclear Cloning and Reprogramming of the Genome.

Dr. Philippe SLOS

Dr. Philippe SLOS (1,9 Mo)
Head of the Preclinical Regulatory Department of Transgene SA, Strasbourg-France
Cancer Immunotherapy with viral vectors.